Thermo Fisher Scientific, Inc. TMO recently launched the Applied Biosystems CytoScan HD Accel array — a new chromosomal microarray intended to enhance cytogenetic research lab productivity, efficiency ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ ...
Most comprehensive and ethnically diverse genomic coverage on a high throughput microarray delivers multi-disease and pharmacogenomic research analysis across global populations CARLSBAD, ...
Thermo Fisher Scientific has introduced the Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer, designed for fast and scalable sample analysis. In conjunction with two new arrays – the Applied ...
Officials at Thermo Fisher Scientific say the company’s new SmartPlex platform shifts microarrays to a 96-well configuration, thus evolving toward an ELISA-like format that increases the speed and ...
Thermo Fisher Scientific Inc. TMO recently partnered with the Qatar Genome Program (QGP), a member of the Qatar Foundation, to expedite genomic research and clinical applications of predictive ...
Join us for an insightful webinar on the use of polygenic risk scores (PRS) for cardiovascular disease (CVD). The analysis of genetic variation across large populations plays a crucial role in ...
Stem cells and organoids are revolutionising medical advancements. The journey from stem cell research to translational medicine is extensive, and maintaining quality throughout development and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results